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Figure 3 Sequence of alleles present in family Z. Alleles 1 and 2 differ at position /3 of the intron. Allele 3 differs, at intronic position
/17, from alleles 1 and 2. The mutation A1244G is present on the background of allele 1.
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No Overlap with the DiGeorge Syndrome Critical
This work was supported by Institut National de la Sante´ Region
et de la Recherche Me´dicale (INSERM), the Centre National
To the Editor:pour la Recherche Scientiﬁque, Association Franc¸aise contre
les Myopathies, and the Centre Hospitalier Re´gional et Uni- Recent data indicate that the etiology of DiGeorge syn-
versitaire de Strasbourg. drome (DGS) and velo-cardio-facial syndrome (VCFS) is
more complex than previously thought, with one recent
report suggesting the existence of a second ‘‘critical re-References
gion’’ within 22q11 (Kurahashi et al. 1996). Here we
Dahl N, Hu LJ, Chery M, Fardeau M, Gilgenkrantz S, Ni- report another patient, with a mild phenotype, who has
velon-Chevallier A, Sidaner-Noisette I, et al (1995) Myotu- a deletion distinct from, and distal to, the established
bular myopathy in a girl with a deletion at Xq27-q28 and proximal critical region.
unbalanced X inactivation assigns the MTM1 gene to a 600-
Interstitial deletions within human chromosomekb region. Am J Hum Genet 56:1108–1115
22q11 have been described in patients with DGS (Scam-Hu LJ, Laporte J, Kioschis P, Heyberger S, Kretz C, Poustka
bler et al. 1991; Driscoll et al. 1992a), VCFS (DriscollA, Mandel JL, et al (1996a) X-linked myotubular myopathy:
et al. 1992b; Scambler et al. 1992), and conotruncalreﬁnement of the gene to a 280-kb region with new and
anomaly face (CTAF) (Burn et al. 1993) and in a minor-highly informative microsatellite markers. Hum Genet 98:
178–181 ity of patients with overlap between VCFS and Opitz
Hu LJ, Laporte J, Kress W, Dahl N (1996b) Prenatal diagnosis GBBB (McDonald-McGinn et al. 1995). They also have
of X-linked myotubular myopathy: strategies using new and been reported in many instances in which the full spec-
tightly linked DNA markers. Prenat Diagn 16:231–237 trum of these syndromes is not evident—for instance,
Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, Coy JF, in congenital heart disease (Wilson et al. 1992). How-
Klauck SM, et al (1996) A gene mutated in X-linked myotu- ever, in these cases there is usually facial dysmorphism
bular myopathy deﬁnes a new putative tyrosine phosphatase
typical of that seen in VCFS. Since both mild and severefamily conserved in yeast. Nat Genet 13:175–182
malformations, as well as birth defects affecting distinctSamson F, Mesnard L, Heimburger M, Hanauer A, Chevallay
organ systems, can occur in the same family, these vari-M, Mercadier JJ, Pelissier JF, et al (1995) Genetic linkage
ous abnormalities are generally thought to share theheterogeneity in myotubular myopathy. Am J Hum Genet
same genetic etiology—namely, haploinsufﬁciency for57:120–126
Wallgren-Pettersson C, Clarke A, Samson F, Fardeau M, Du- a gene(s) within 22q11.
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Several investigators have compared 22q11 deletions,
in order to establish a shortest region of deletion overlap
(SRO). Comparison of the position and extent of dele-
tions does not suggest any simple genotype/phenotype
correlation. The interstitial deletions reported have al-
most all been large, involving the same region of Ç2
Mb. Examination of terminal deletions enabled us to
establish an SRO of Ç500 kb (Halford et al. 1993).
Others have narrowed this further, to Ç250 kb (Gong
et al. 1996). Although this region evidently contained
more than one gene, the balance of evidence favored
the hypothesis that the birth defects are secondary to
haploinsufﬁciency of a single gene, since a balanced 2;22
translocation breakpoint, ADUBP, mapped within the
SRO. Positional cloning efforts concentrated on identi-
ﬁcation of genes in the proximity of the ADUBP.
Three groups have reported cloning of sequences at
or adjacent to the ADU breakpoint (Budarf et al. 1995;
Demczuk et al. 1995; Wadey et al. 1995). However,
no gene isolated from this region can be unequivocally
implicated in DGS. Budarf and colleagues sequenced the
disrupted sequences within ADU and identiﬁed an open
reading frame disrupted by ADUBP, but no cDNA en-
coding this open reading frame could be isolated (Budarf
et al. 1995). A gene, DGCR5, spanning the balanced
translocation has been cloned, but it does not appear to
code for a protein (Sutherland et al. 1996). The struc-
tural gene closest to the ADU breakpoint is DGCR2/
IDD, encoding a transmembrane protein (Demczuk et
al. 1995; Wadey et al. 1995). However, none of these
sequences appears to have a point mutation in any pa- Figure 1 Top, Map of 22q11 deletion breakpoints. The relative
position of 22q11 markers is shown at the top of the panel; and thetient without a 22q11 deletion.
positions of various deletion breakpoints are given at the bottom ofLevy et al. (1995) and colleagues reported a child
the panel, with the ADUBP depicted by the jagged line. The superscript(patient G) with DGS and a 22q11 deletion that did not ‘‘1’’ and ‘‘2’’ indicate MDGCR, as deﬁned by Gong et al. (1996), in
extend into the region disrupted in ADU. One possible relation to the SRO seen in patients whom we have analyzed—namely,
interpretation (Levy et al. 1995) is that the ADU GM00980 and G. The superscript ‘‘3’’ indicates the putative second
SRO, as proposed by Kurahashi et al. (1996), distal to and distinctbreakpoint exerts a position effect on a gene(s) located
from the proximal SRO. The deletion analyzed here (NA) overlapsdistally within the reﬁned SRO. Most recently, Kura-
with the distal SRO and is similarly distinct from the proximal SRO.hashi et al. (1996) described a patient with CTAF and Bottom, Pedigree of family A.
a deletion that did not overlap with the SRO located
proximally (see ﬁg. 1, top), and they suggested the exis-
tence of a second critical region located distally within defect, septum primum atrial septal defect, patent ductus
arteriosus and dextrarotation, and hypothyroidism. Shethe frequently deleted region. The location and number
of genes involved in VCFS/DGS is therefore currently in also had slightly short limbs, but a skeletal survey re-
vealed no speciﬁc dysplasia. The parents were normaldoubt.
In this paper we report on the mapping of a 22q11 on examination and echocardiography but were ﬁrst
cousins. Patient NA (II.2) had normal limbs and, atdeletion found in one member of a family referred on
the basis of familial congenital heart defect. The deletion birth, a ventricular septal defect that did not require
surgical intervention and closed spontaneously. No im-in this patient is distal to the proximal SRO but overlaps
with the deletion reported by Kurahashi. mune studies have been conducted, since there is a his-
tory of typical childhood infections only. There is noFamily A (pedigree in ﬁg. 1, bottom) was screened
with 22q11 markers, since three children had congenital documented instance of hypocalcemia, but parathyroid-
function studies were not performed. The palate andheart defects. One child (II.3) had died as a consequence
of the heart defects, and no sample was available for facies are normal, and there is no nasal intonation to
the speech. Learning and behavior are normal. Childanalysis. She had an inlet muscular ventricular septal
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Figure 2 FISH analysis of patient NA’s metaphase chromosomes, with 22q11 markers. Arrowheads are used to indicate chromosome
22. Panels a and b show, respectively, markers scF5 and N60C11, both of which detect signal on both chromosomes 22; these markers map
proximal to the deletion. Panels c and d show, respectively, markers DO832 and N122B5, which detect signal on only one chromosome 22;
these markers are within the deletion. Panels e and f show, respectively, markers 118D3 and N14C6, which detect signal on both chromosomes
22; these markers are distal to the 22q11 deletion. The chromosome 22 centromeric marker D22Z1 (which also detects chromosome 14) has
been used to identify both chromosomes 22 in some hybridizations, including those in which there is test probe signal only on the nondeleted
chromosome (c and d).
II.1 had a cardiomyopathy but no stigmata of VCFS or NA is hemizygous for cosmid N122B5 and dizygous
for the mega-YAC 118D3. Interrogation of the SangerDGS and had normal limbs; cardiomyopathy is not a
feature of 22q11 deletions. A fourth child, born after the center database revealed that both these markers are
contained within the mega-YAC M652G7; therefore,chromosome analysis, had the short-limbed phenotype.
A routine diagnostic test revealed that NA was dizy- the distal deletion breakpoint must be within mega-YAC
M652G7. No analysis with HKAD was conducted.gous for the marker N25 (D22S75) but hemizygous for
cosmid D0832 (see map in ﬁg. 1, top). In order to con- However, the HKAD cosmid and the mega-YAC
M652G7 both contain the LZTR gene, so the distalﬁrm and extend these unexpected ﬁndings, a series of
markers from across the commonly deleted region (Col- extents of these two atypical deletions are similar.
FISH analysis demonstrates that patient NA has anlins et al. 1995; Morrow et al. 1995) were examined to
map the proximal and distal extents of deletion. FISH atypically small 22q11 deletion. This is the third 22q11
deletion that does not extend into the region disruptedanalysis demonstrated dizygosity for markers sc11.1,
scF5 (ﬁg. 2a), and N60C11 (ﬁg. 2b). Markers D0832 by the ADU balanced-translocation breakpoint, but,
more strikingly, the deletion does not overlap with the(ﬁg. 2c) and N122B5 (ﬁg. 2d) detected hemizygosity in
patient NA, whereas sequences detected by 118D3 and previously described SRO for DGS/VCFS. The distal ex-
tent of our SRO is deﬁned by the deletion seen in cellN14C6 were dizygous (ﬁg. 2e and f ).
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line GM00980 (Halford et al. 1993). Cosmid N60C11 Acknowledgments
is dizygous in GM00980 and therefore maps distal to
The MRC (U.K.) and British Heart Foundation provided
the SRO (Halford et al. 1993). N60C11 is also dizygous generous support.
in patient NA, mapping proximal to the deletion. Both
parents had normal chromosomes and were dizygous
Referencesfor N25 and D0832. These observations were corrobo-
rated by microsatellite analysis (B. Morrow, unpub- Budarf ML, Collins J, Gong W, Roe B, Wang Z, Bailey LC,
lished data). Sellinger B, et al (1995) Cloning a balanced translocation
In the absence of a complete transcription map of associated with DiGeorge syndrome and identiﬁcation of a
22q11, it is not possible to state unequivocally that dis- disrupted candidate gene. Nat Genet 10:269–278
Burn J, Takao A, Wilson DI, Cross I, Momma K, Wadey R,tinct genes are affected in ADU, in patients G and NA.
Scambler PJ, et al (1993) Conotruncal anomaly face syn-However, since the distance from the ADU breakpoint
drome is associated with the deletion within chromosometo the proximal boundary of the NA deletion is §500
22q11. J Med Genet 30:822–824kb, this does seem unlikely. Since the deletion in NA is
Collins JE, Cole CG, Smink LJ, Garrett CL, Leversha MA,likely to overlap with the deletion observed in the CTAF
Soderlund CA, Maslen GL, et al (1995) A high resolutionpatient of Kurahashi et al. (1996), it seems most proba-
integrated yeast artiﬁcial chromosome clone map of human
ble that the phenotype in these two patients is secondary chromosome 22. Nature Suppl 377:367–379
to haploinsufﬁciency of the same gene(s). Demczuk S, Aledo R, Zucman J, Delattre O, Desmaze C, Dau-
The mild phenotype observed in NA is worthy of phinot L, Jalbert P, et al (1995) Cloning of a balanced trans-
comment, since, apart from the previous history of hav- location breakpoint in the DiGeorge syndrome critical re-
ing had a VSD, she could be described as unaffected. gion and isolation of a novel potential adhesion receptor
gene in its vicinity. Hum Mol Genet 4:551–558Her sib had a more complex congenital heart defect, but
Driscoll DA, Budarf ML, Emanuel B (1992) A genetic etiologyno material was available for analysis. Evidently there
for DiGeorge syndrome: consistent deletions and microdele-is the possibility of a germinal mosaicism in this family,
tions of 22q11. Am J Hum Genet 50:924–933and there may be an independently segregating recessive
Driscoll DA, Spinner NB, Budarf ML, McDonald-McGinnmutation resulting in a mild shortening of the limbs.
PM, Zackai EH, Goldberg RB, Shprintzen RJ, et al (1992)Interestingly, the CTAF patient with a small distal dele-
Deletions and microdeletions of 22q11.2 in VCFS. Am J
tion also had a heart defect (pulmonary atresia and te- Med Genet 44:261–268
tralogy of Fallot), and no hypoparathyroidism or cell- Gong W, Emanuel BS, Collins J, Kim DH, Wang Z, Chen F,
mediated immune deﬁciency was reported. It is possible Zhang G, et al (1996) A transcription map of the DiGeorge
that deletions within the distal ‘‘critical’’ region are more and velo-cardio-facial syndrome minimal critical region on
likely to result in a restricted phenotype, for which 22q11. Hum Mol Genet 5:789–800
karyotype analysis might not be requested. In any case, Halford S, Wadey R, Roberts C, Daw SCM, Whiting JA,
O’Donnell H, Dunham I, et al (1993) Isolation of a putativeexamination with the commercially available probes
transcriptional regulator from the region of 22q11 deletedwould not detect their deletions.
in DiGeorge syndrome, Shprintzen syndrome and familialIt might be argued that the mild heart defect is due
congenital heart disease. Hum Mol Genet 2:2099–2107to factors other than a 22q11 deletion. In this case, it
Kurahashi H, Nakayama T, Osugi Y, Tsuda E, Masuno M,must be concluded that the deletion has no effect even
Imaizumi K, Kamiya T, et al (1996) Deletion mapping ofthough it covers approximately the same region as the
22q11 in CATCH22 syndrome: identiﬁcation of a secondCTAF distal deletion (Kurahashi et al. 1996). The hy- critical region. Am J Hum Genet 58:1377–1381
pothesis that distal deletions predispose to less severe Levy A, Demczuk S, Aurias A, Depetris D, Mattei MG, Philip
defects than proximal deletions is robust against this N (1995) Interstitial 22q11 deletion excluding the ADU
objection. The number and location of genes involved breakpoint in a patient with DGS. Hum Mol Genet 4:2417–
in DGS/VCFS remains in doubt, with the identiﬁcation 2418
of these genes made more difﬁcult by the existence of McDonald-McGinn DM, Driscoll DA, Bason L, Christensen
K, Lynch D, Sullivan K, Canning D, et al (1995) Autosomalnonoverlapping deletions and the likelihood of position
dominant ‘‘Opitz’’ GBBB syndrome due to a 22q11.2 dele-effects within the region (Sutherland et al. 1996).
tion. Am J Med Genet 59:103–113HILARY O’DONNELL,1 CAROLE MCKEOWN,2 CLIVE
Morrow B, Goldberg R, Carlson C, Das Gupta R, Sirotkin H,GOULD,3 BERNICE MORROW,4 AND PETER SCAMBLER1
Collins J, Dunham I, et al (1995) Molecular deﬁnition of1Molecular Medicine Unit, Institute of Child Health, the 22q11 deletions in velo-cardio-facial syndrome. Am J
London; 2West Midlands Regional Clinical Genetics Hum Genet 56:1379–1390
Service, Birmingham Maternity Hospital, and Scambler PJ, Carey AH, Wyse RKH, Roach S, Dumanski JP,
3Department of Cytogenetics, Heartlands Hospital, Nordenskjold M, Williamson R (1991) Microdeletions
Birmingham, United Kingdom; and 4Molecular within 22q11 associated with sporadic and familial Di-
George syndrome. Genomics 10:201–206Genetics, Albert Einstein College of Medicine, Bronx
/ 9a2a$$ju16 05-23-97 18:35:01 ajhga UC-AJHG
1548 Letters to the Editor
Scambler PJ, Kelly D, Williamson R, Goldberg R, Shprintzen morphism at the stop codon (1118ArC) of the MJD1
R (1992) The velo-cardio-facial syndrome is associated with cDNA, resulting in the addition of 16 amino acid resi-
chromosome 22 deletions which encompass the DiGeorge dues to the C-terminal domain of the gene product, that
syndrome locus. Lancet 339:1138–1139 does not affect the phenotype. Analysis of the haplotypes
Sutherland HF, Wadey R, McKie JM, Taylor C, Atif U, John- deﬁned by the 987GrC and 1118ArC polymorphisms
stone KA, Halford S, et al (1996) Identiﬁcation of a novel
revealed the existence of four different haplotypes asso-transcript disrupted by a balanced translocation associated
ciated with the SCA3/MJD mutation that have resultedwith DiGeorge syndrome. Am J Hum Genet 59:23–31
from at least four ancestral mutations.Wadey R, Daw S, Taylor C, Atif U, Kamath S, Halford S,
We have cloned cDNAs corresponding to the nor-O’Donnell H, et al (1995) Isolation of a gene encoding an
mal and expanded MJD1 alleles from a SCA3/MJDintegral membrane protein from the vicinity of a balanced
translocation breakpoint associated with the DiGeorge syn- patient, by retro-transcription of brain mRNA fol-
drome. Hum Mol Genet 4:1027–1034 lowed by PCR. Direct sequencing of both cDNAs re-
Wilson DI, Goodship JA, Burn J, Cross IE, Scambler PJ (1992) vealed at codon 359 a polymorphism that differs from
Deletions within chromosome 22q11 in familial congenital the published MJD1 sequence (Kawaguchi et al.
heart disease. Lancet 340:573–575 1994) and that corresponds to a 1118ArC substitu-
tion (TerrY) predicting an SCA3/MJD protein con-
Address for correspondence and reprints: Dr. Peter J. Scambler, Room 214, taining 16 additional amino acid residues (YELHVI-
Molecular Medicine Unit, Institute of Child Health, 30, Guilford Street, London
FALHYSSFPL). This result is in agreement withWC1N 1EH, UNited Kingdom. E-mail: pscamble@hgmp.mrc.ac.uk
 1997 by The American Society of Human Genetics. All rights reserved. preliminary results obtained on cDNA from lymph-
0002-9297/97/6006-0036$02.00 oblastoid mRNA (Trottier et al. 1995) and from a
brain library (Goto et al. 1996). The polymorphisms
can be detected rapidly by differential PCR with the
MJD52 primer (Kawaguchi et al. 1994) and either
MJD-TAA (GCAAAAATCACATGGAGCTCT) or
Am. J. Hum. Genet. 60:1548–1552, 1997 MJD-TAC (GCAAAAATCACATGGAGCTCG) for
the 1118ArC polymorphism and either MJD-GGG
(CTCTGTCCTGATAGGTCCCC) or MJD-CGGLinkage Disequilibrium between the Spinocerebellar
(CTCTGTCCTGATAGGTCCCG) for the 987GrCAtaxia 3/Machado-Joseph Disease Mutation and Two
polymorphism. PCR ampliﬁcations were performedIntragenic Polymorphisms, One of Which, X359Y,
as described elsewhere (Cancel et al. 1995), exceptAffects the Stop Codon
for annealing at 64C and 63C for the 1118ArC and
To the Editor: 987GrC polymorphisms, respectively. PCR products
were separated on 1% agarose gels and were visual-Machado-Joseph disease (Takiyama et al. 1993) or
spinocerebellar ataxia 3 (Stevanin et al. 1994a) (SCA3/ ized by UV exposure in the presence of 0.5 mg ethid-
ium bromide/ml (ﬁg. 1). PCR products from controlMJD), is the most frequent form of autosomal dominant
cerebellar ataxia type I, a heterogeneous group of neuro- subjects who were homozygous for a polymorphism
on both normal chromosomes were run on 6% acryl-degenerative disorders of unknown etiology (Harding
amide gels for better resolution of the alleles and were1993; Sequeiros and Coutinho 1993; Du¨rr and Brice
visualized by autoradiography, after being blotted1996; Du¨rr et al. 1996). The responsible mutation has
onto nylon membranes and hybridized with a g32P-been characterized as an unstable CAG-repeat expan-
labeled (CAG)7 oligonucleotide.sion in the coding region of the MJD1 gene (Kawaguchi
et al. 1994; Cancel et al. 1995). The molecular mecha-
nism leading to repeat expansion remains unknown.
However, Igarashi et al. (1996) recently suggested, on
the basis of an intragenic polymorphism (987GrC) in
the MJD1 gene, that an allelic interaction between the
normal and expanded chromosomes may be implicated
in the instability of the expanded CAG repeat. Until
recently, the SCA3/MJD mutation was thought to origi-
nate in the Azores Islands. We now know that the dis-
ease is not restricted to patients of Portuguese descent
and that several different mutations probably are in-
Figure 1 Detection of the four 987GrC/1118ArC haplotypes
volved, even in Portuguese pedigrees (Stevanin et al. on expanded SCA3/MJD alleles. The four PCR ampliﬁcations (see
1995a; Takiyama et al. 1995; Gaspar et al. 1996; Iugh- text) for each subject were run on a 1% agarose gel containing 0.5
mg of ethidium bromide/ml, to separate normal and expanded alleles.etti et al. 1996). We report here a new intragenic poly-
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